ライフサイエンスコーパス: hopelessness

1 (e.g. nervousness, tension, catastrophizing, hopelessness).

2 may be motivated by depression or short-term hopelessness.

3 ion of patients and between satisfaction and hopelessness.

4 < .001) but not for anxiety, depression, or hopelessness.

5 gy, suicide history, reasons for living, and hopelessness.

6 as anhedonia, guilt, suicidal thinking, and hopelessness.

7 al health outcomes, such as fear for life or hopelessness.

8 , sensation seeking, anxiety sensitivity, or hopelessness.

9 lity, Interpersonal Conflict, Overwhelm, and Hopelessness.

10 with improvement in cognitive biases such as hopelessness (-0.97, 95% CI: -1.72, -0.23), rumination (

11 we observed mediation through reductions in hopelessness (1.92%; P = 0.01), trait anger (1.98%; P =

12 (811 [37.5%]) reported past-year feelings of hopelessness; 587 (27.2%), past-year nonsuicidal self-in

13 vely emotional symptoms (bothered by things, hopelessness about the future, felt fearful, life had be

14 were associated with lower odds of past-year hopelessness after adjusting for covariates.

15 gency) and three-month outcomes (depression, hopelessness, agency, generalized anxiety, COVID-19-rela

16 d significantly higher levels of depression, hopelessness, aggression, anxiety, impulsivity, and suic

17 as associated with lower odds of feelings of hopelessness among youths.

18 s IL-6, beta = -0.282,p = 0.003, and between hopelessness and a flatter cortisol slope, beta = 0.211,

19 SSI's effects on post-intervention outcomes (hopelessness and agency) and three-month outcomes (depre

20 y diverse debilitating symptoms that include hopelessness and anhedonia.

21 erized by symptoms such as reduced activity, hopelessness and depressed mood.

22 Hopelessness and despair are growing problems particular

23 Hopelessness and despair threaten health and longevity.

24 Psychometric features such as neuroticism, hopelessness and emotional symptoms were the main contri

25 Hopelessness and impulsive aggression independently incr

26 by anhedonia, cognitive biases, ruminations, hopelessness and increased anxiety.

27 objective severity of depression, may modify hopelessness and may protect against suicidal behavior d

28 lated with depression severity, self-report 'hopelessness' and anxiety.

29 tive outcomes included social connectedness, hopelessness, and academic and vocational participation.

30 sulted in intense terror, grief, exhaustion, hopelessness, and isolation.

31 of life, whereas symptom distress, concerns, hopelessness, and negative appraisal of illness or careg

32 ikely to be religious, had higher scores for hopelessness, and rated their quality of life as lower.

33 he cognitive factors of attributional style, hopelessness, and self-esteem were assessed in subjects

34 he cognitive factors of attributional style, hopelessness, and self-esteem when suicidal ideation fad

35 among those with lower baseline depression, hopelessness, and self-reported anxiety.

36 Interventions addressing depression, hopelessness, and social support appear to be important

37 istically significant reduction in distress, hopelessness, and suicidal ideation at three months, but

38 out a history of abuse, with lower levels of hopelessness, and with comorbid conditions.

39 into eight symptom complexes, namely sadness/hopelessness, anhedonia/lack of energy, anxiety/irritabi

40 dently predicted by nonsuicidal self-injury, hopelessness, anxiety disorder, and being younger and fe

41 h elevated scores on self-report measures of hopelessness, anxiety sensitivity, impulsivity, and sens

42 ratings of psychiatric symptoms (depression, hopelessness, anxiety, feeling overwhelmed, agitation, a

43 At week 12, lower depression, hopelessness, anxiety, suicidal ideation, family conflic

44 Secondly, we examined whether hope and hopelessness are distinctly associated with these biomar

45 Prior attempted suicide and hopelessness are the most powerful clinical predictors o

46 Depression and hopelessness are the strongest predictors of desire for

47 v SGP) for quality of life, depression, and hopelessness but not for other outcome variables.

48 men with high scores on the helplessness and hopelessness category of the MAC scale compared with tho

49 nd caregiving, greater uncertainty, and more hopelessness compared with dyads in the newly diagnosed

50 ces suicide attempts, suicidal ideation, and hopelessness compared with treatment as usual (TAU).

51 or academic performance, poor sleep quality, hopelessness, compromised physical and mental health, hi

52 decreased post-intervention and three-month hopelessness (d = 0.16-0.28), increased post-interventio

53 associated with suicidal behaviour only (eg, hopelessness, depression, anxiety, quality of life).

54 to criteria modified for the medically ill (hopelessness, depression, or anhedonia were used as the

55 nificantly greater reductions in depression, hopelessness, desire for hastened death, and physical sy

56 ndary outcome measures assessing depression, hopelessness, desire for hastened death, anxiety, and ph

57 past 12 months, which comprised feelings of hopelessness (feeing so sad or hopeless that you stopped

58 overall psychopathology, suicidal ideation, hopelessness, functional impairment, attendance at thera

59 ), anorexia (N=1), and demoralization (i.e., hopelessness, helplessness, and poor coping) in AIDS sur

60 Evidence of hopelessness, helplessness, worthlessness, guilt, and su

61 episode alone on measures of depressed mood, hopelessness, impulsive aggression, and suicidal behavio

62 ngers online significantly predicted greater hopelessness in the future of America.

63 ories with messages that could contribute to hopelessness in those experiencing economic difficulties

64 feelings of worthlessness, helplessness, and hopelessness, in the desipramine-mazindol but not in the

65 tress, depression, anxiety, uncertainty, and hopelessness interact with pain.

66 fect size across cases, these variables were hopelessness, lack of control, anxiety, feeling blocked,

67 predicted reduced levels of postconsultation hopelessness (linear change, -0.78; 95% CI, 1.44 to -0.1

68 t 1 depressive symptom (sadness, depression, hopelessness, loss of interest, or lack of pleasure) was

69 , root causes of the opioid epidemic such as hopelessness need to be identified and addressed.

70 Levels of hopelessness of patients significantly decreased from pr

71 te and trainable PCC behaviors can lower the hopelessness of patients with breast cancer indirectly t

72 which, in turn, reduces the postconsultation hopelessness of patients.

73 psychological pain (e.g., social isolation, hopelessness), often in the context of mental disorders,

74 n increase in either impulsive aggression or hopelessness or a diagnosis of borderline personality di

75 on, decreased depressive severity, decreased hopelessness, or improved level of function.

76 evel of subjective and objective depression, hopelessness, or stressful life events were found.

77 ysiological symptoms of anxiety (p 0.05) and hopelessness (p 0.013), and lower (worse) for physical f

78 ltivariate analyses, depression (P=.003) and hopelessness (P<.001) provided independent and unique co

79 of depressive symptom severity (P<.001) and hopelessness (P<.001).

80 n treatment, leukemia diagnosis, depression, hopelessness, pain, and physical appearance concern.

81 Depressive symptoms (depression, hopelessness, perceived burdensomeness, and anhedonia) w

82 Hopelessness predicted lethal intent in all three groups

83 ing and desire for hastened death (r=-0.51), hopelessness (r=-0.68), and suicidal ideation (r=-0.41).

84 , and a limited set of symptoms (depression, hopelessness, rejection sensitivity, and perceived burde

85 cluding suicidal and death-related thoughts, hopelessness, restlessness and agitation, insomnia and i

86 re associated with lower scores for the Beck Hopelessness Scale (pooled mean difference, -2.35 [95% C

87 entory, Spielberger-Trait Anxiety Inventory, Hopelessness Scale, and Quality of Life Questionnaire SF

88 e Hamilton depression rating scale, the Beck hopelessness scale, and the schedule of attitudes toward

89 s, the Brief Symptom Inventory, and the Beck Hopelessness Scale; stage of HIV illness; and CD4 cell c

90 year event-free survival a high helplessness/hopelessness score has a moderate but detrimental effect

91 Secondary analyses including both hope and hopelessness showed similar patterns, with distinct rela

92 between certain psychosocial factors (e.g., hopelessness, social support) and cancer progression.

93 t psychosocial well-being (social isolation, hopelessness, stigma of illness, and balancing personal

94 n secondary measures of depression, anxiety, hopelessness, stress, and quality of life.

95 Scores for hopelessness, subjective depression, and suicidal ideati

96 Secondary outcomes were distress, hopelessness, suicidal ideation, and health related qual

97 nts in the secondary outcomes of depression, hopelessness, suicidal ideation, and problem solving.

98 sures of psychological distress (depression, hopelessness, suicidal ideation, overall psychological d

99 ndary outcomes included anxiety, depression, hopelessness, symptom burden, and symptom-related distre

100 ase in depression severity and reported less hopelessness than the patients receiving usual care.

101 ility that depression can lead to a sense of hopelessness that erodes adherence and other health-prom

102 ng spirit or an attitude of helplessness and hopelessness toward the disease, has been suggested as a

103 style became significantly more positive and hopelessness was decreased from admission to discharge,

104 For example, hopelessness was significant in seven of the seven cases

105 Hope and hopelessness were assessed using standardized survey ite